DrugLogic

From Wikipedia, the free encyclopedia
Jump to: navigation, search
DrugLogic, Inc.
Private
Industry Computer software
Founded 2003
Headquarters Reston, Virginia
Key people
Website www.druglogic.com

DrugLogic, Inc. is a software company headquartered in Reston, Virginia. It has offices in Boston, Massachusetts, Princeton, New Jersey, San Diego, California, and Irvine, California.

The company provides analytic, workflow, and risk management software and services for the pharmaceutical and related industries.

The product line includes

  • Qscan-ERM, the analytic, workflow, and risk management platform
  • Qnome, a specialized version of Qscan-ERM for use with genomic information.
  • Qmap, a platform for mapping structured data.

U.S. Patents[edit]

DrugLogic, Inc. is granted or is in the process of applying for the following patents with the United States Patent and Trademark Office:

  • 6,778,994 Pharmacovigilance database[1]
  • 6,789,091 Method and system for web-based analysis of drug adverse effects[2]
  • 7,461,006 Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data[3]
  • 7,542,961 Method and system for analyzing drug adverse effects[4]
  • 7,925,612 Method for graphically depicting drug adverse effect risks[5]
  • 8,694,555 Processing drug data[6]
  • Method and system for drug utilization review[7]
  • Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data[8]
  • Method and system for creating, storing and using patient-specific and population-based genomic drug safety data[9]
  • Method and system for analyzing drug adverse effects[10]
  • Method for analyzing drug adverse effects employing multivariate statistical analysis[11]

References[edit]

  1. ^ Pharmacovigilance database
  2. ^ Method and system for web-based analysis of drug adverse effects
  3. ^ Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data [1]
  4. ^ Method and system for analyzing drug adverse effects
  5. ^ Method for graphically depicting drug adverse effect risks
  6. ^ Processing drug data
  7. ^ Method and system for drug utilization review
  8. ^ Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data [2]
  9. ^ Method and system for creating, storing and using patient-specific and population-based genomic drug safety data [3]
  10. ^ Method and system for analyzing drug adverse effects
  11. ^ Method for analyzing drug adverse effects employing multivariate statistical analysis [4]

External links[edit]